Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

Market Cap	2.75B
Revenue (ttm)	441.86M
Net Income (ttm)	2.24M
Shares Out	93.57M
EPS (ttm)	0.02
PE Ratio	1,230.28
Forward PE	n/a
Dividend	0.10 (0.35%)
Ex-Dividend Date	May 29, 2025

Volume	2,501,856
Average Volume	2,790,178
Open	29.89
Previous Close	29.42
Day's Range	28.52 - 30.47
52-Week Range	13.84 - 46.59
Beta	0.43
RSI	44.83
Earnings Date	Aug 15, 2025

About SHA:688393

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 796
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688393

Financial Performance

In 2024, SHA:688393's revenue was 470.79 million, a decrease of -5.33% compared to the previous year's 497.29 million. Earnings were 21.29 million, a decrease of -46.85%.